Skip to main content
Equibles

DEUTSCHE BANK AG\

Bank

Position in IMVT — Immunovant, Inc.

CIK 948046 FRANKFURT AM MAIN, 2M
Back to IMVT Full portfolio

Position in IMVT

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$3,798,865
+$1,836,506 QoQ
Shares Held
98,595
+24.8% QoQ
Ownership
0.048%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#65
of 226 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority Sole 12% Shared 0% None 88%

Common Shares in IMVT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

DEUTSCHE BANK AG\ holds $3,199,137,357 across 296 Biotechnology names. IMVT ranks #74 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,579,110 $784,391,303
2 REGN
Regeneron Pharmaceuticals, Inc.
 518,409 $323,248,743
3 ALNY
Alnylam Pharmaceuticals, Inc.
 815,400 $245,459,858
4 RVMD
Revolution Medicines, Inc.
 888,019 $166,308,196
5 RPRX
Royalty Pharma plc
 2,717,951 $152,395,510
6 INCY
Incyte Corp
 1,262,988 $143,172,312
7 ARGX
Argenx SE
 137,335 $127,415,291
8 LGND
Ligand Pharmaceuticals Inc
 249,611 $78,899,539

All Filings in IMVT

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,798,865 98,595
2026-03-31 $1,962,359 79,000
2025-12-31 $1,587,682 62,458
2025-09-30 $883,133 54,785
2025-06-30 $780,336 48,771
2025-03-31 $7,032,688 411,509
2024-12-31 $4,123,511 166,472
2024-09-30 $4,264,211 149,569
2024-06-30 $3,774,513 142,974
2024-03-31 $4,698,681 145,425
2023-12-31 $6,083,276 144,393
2023-09-30 $1,343,380 34,993
2023-06-30 $2,706,677 142,682
2023-03-31 $623,827 40,221
2022-12-31 $567,432 31,968
2022-09-30 $148,354 26,587
2022-06-30 $75,387 19,330
2022-03-31 $130,079 23,608
2021-12-31 $1,249,346 146,637
2021-09-30 $1,260,822 145,089
2021-06-30 $1,949,709 184,457
2021-03-31 $2,565,532 159,946
2020-12-31 $1,440,249 31,181
2020-09-30 $741,663 21,076
2020-06-30 $2,875,660 118,097